Danaher Corp., US2358511028

Danaher stock: Cepheid wins IVDR mark for respiratory panel

Published on 11/16/2026 at 16:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher stock gets a new regulatory catalyst as Cepheid secures IVDR CE marking for its Xpert Respiratory Panel. The test targets 13 pathogens.

New respiratory diagnostic milestone

  • Cepheid received IVDR CE marking for a multiplex PCR panel covering 13 respiratory pathogens.
  • The test runs on existing GeneXpert systems and is scheduled to ship to accepting countries in the coming weeks.
  • The regulatory step broadens Danaher's respiratory diagnostics portfolio.
Danaher Corp., US2358511028, Illustration mit AI erstellt.

Danaher stock traded at 210.70 euros on Lang & Schwarz at 16:05 CET on Monday, November 16, 2026. The company also has a fresh regulatory development in its diagnostics business: Cepheid received IVDR CE marking for its Xpert Respiratory Panel on November 10.

Regulatory milestone expands respiratory portfolio

According to Cepheid's news release, the multiplex PCR test is designed to detect 13 common viral and bacterial respiratory pathogens from a single nasopharyngeal swab. The panel is intended to support the assessment of suspected respiratory tract infections alongside other clinical and laboratory information.

The test runs on existing GeneXpert systems, allowing healthcare providers to use the installed platform for targeted, mid-plex or broader respiratory testing. Cepheid said the panel requires less than one minute of hands-on time and delivers on-demand results.

Commercial rollout comes next

Cepheid said shipments to countries that accept the CE mark will begin in the coming weeks. The announcement expands the company's respiratory testing range, while the initial release does not provide a revenue forecast or a country-by-country launch schedule.

For investors, the regulatory milestone adds a new product event to Danaher's diagnostics portfolio. Its financial impact will depend on adoption, availability and the conversion of testing demand into recurring instrument and consumables sales.

Broader market context is covered in Current market reports.

More news and analyses on Danaher stock

Danaher Corporation at a glance

  • Company: Danaher Corporation
  • ISIN: US2358511028
  • Quoted price: 210.70 euros on Lang & Schwarz at 16:05 CET on November 16, 2026
Disclaimer...
en | US2358511028 | DANAHER CORP. | boerse | 70521461 | bgmi